Mithra Pharmaceuticals SA MITRA.BR Stock
Mithra Pharmaceuticals SA Price Chart
Mithra Pharmaceuticals SA MITRA.BR Financial and Trading Overview
| Mithra Pharmaceuticals SA stock price | 0.23 EUR |
| Previous Close | 2.62 EUR |
| Open | 2.75 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 2.65 - 2.8 EUR |
| 52 Week Range | 2.25 - 9.75 EUR |
| Volume | 228.39K EUR |
| Avg. Volume | 148.25K EUR |
| Market Cap | 155.31M EUR |
| Beta (5Y Monthly) | 0.822222 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.41 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9 EUR |
MITRA.BR Valuation Measures
| Enterprise Value | 451.38M EUR |
| Trailing P/E | N/A |
| Forward P/E | -17.699999 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.318093 |
| Price/Book (mrq) | 4.4397993 |
| Enterprise Value/Revenue | 6.737 |
| Enterprise Value/EBITDA | -21.89 |
Trading Information
Mithra Pharmaceuticals SA Stock Price History
| Beta (5Y Monthly) | 0.822222 |
| 52-Week Change | -58.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.75 EUR |
| 52 Week Low | 2.25 EUR |
| 50-Day Moving Average | 2.6 EUR |
| 200-Day Moving Average | 4.07 EUR |
MITRA.BR Share Statistics
| Avg. Volume (3 month) | 148.25K EUR |
| Avg. Daily Volume (10-Days) | 106.41K EUR |
| Shares Outstanding | 58.5M |
| Float | 37.8M |
| Short Ratio | N/A |
| % Held by Insiders | 31.89% |
| % Held by Institutions | 13.76% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -88.98% |
| Operating Margin (ttm) | -39.17% |
| Gross Margin | 70.71% |
| EBITDA Margin | -30.77% |
Management Effectiveness
| Return on Assets (ttm) | -3.79% |
| Return on Equity (ttm) | -176.58% |
Income Statement
| Revenue (ttm) | 67M EUR |
| Revenue Per Share (ttm) | 1.37 EUR |
| Quarterly Revenue Growth (yoy) | 428.59% |
| Gross Profit (ttm) | 47.37M EUR |
| EBITDA | -20621000 EUR |
| Net Income Avi to Common (ttm) | -59620000 EUR |
| Diluted EPS (ttm) | -1.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 28.29M EUR |
| Total Cash Per Share (mrq) | 0.5 EUR |
| Total Debt (mrq) | 328.14M EUR |
| Total Debt/Equity (mrq) | 974.08 EUR |
| Current Ratio (mrq) | 1.118 |
| Book Value Per Share (mrq) | 0.598 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -56819000 EUR |
| Levered Free Cash Flow (ttm) | -54401000 EUR |
Profile of Mithra Pharmaceuticals SA
| Country | Belgium |
| State | N/A |
| City | Liège |
| Address | Rue Saint-Georges 5 |
| ZIP | 4000 |
| Phone | 32 4 349 28 22 |
| Website | https://www.mithra.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 229 |
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.
Q&A For Mithra Pharmaceuticals SA Stock
What is a current MITRA.BR stock price?
Mithra Pharmaceuticals SA MITRA.BR stock price today per share is 0.23 EUR.
How to purchase Mithra Pharmaceuticals SA stock?
You can buy MITRA.BR shares on the Brussels exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mithra Pharmaceuticals SA?
The stock symbol or ticker of Mithra Pharmaceuticals SA is MITRA.BR.
Which industry does the Mithra Pharmaceuticals SA company belong to?
The Mithra Pharmaceuticals SA industry is Drug Manufacturers-Specialty & Generic.
How many shares does Mithra Pharmaceuticals SA have in circulation?
The max supply of Mithra Pharmaceuticals SA shares is 66.91M.
What is Mithra Pharmaceuticals SA Price to Earnings Ratio (PE Ratio)?
Mithra Pharmaceuticals SA PE Ratio is now.
What was Mithra Pharmaceuticals SA earnings per share over the trailing 12 months (TTM)?
Mithra Pharmaceuticals SA EPS is -1.41 EUR over the trailing 12 months.
Which sector does the Mithra Pharmaceuticals SA company belong to?
The Mithra Pharmaceuticals SA sector is Healthcare.
Mithra Pharmaceuticals SA MITRA.BR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}